on the basis of these results , large-scale controlled therapeutic trails seem warranted in order to establish clinical evidence for the benefit of peroral treatment with 5-aminosalicylic acid in patients with crohn 's disease .
C0030125
aminosalicylic acid
C0010346
crohn 's disease